MintNeuro has been awarded a total of £17 million non-dilutive funding from the UK government's Advanced Research and Invention Agency (ARIA) to develop chip-scale neurotechnologies for clinical settings. The funding will support the custom development and integration of low-power, function-specific integrated circuits and systems, aligned with the mission to develop precise, less invasive, and biologically integrated neurotechnologies.
Company Information
Company
MintNeuro
Location
London, England, United Kingdom
About
MintNeuro is a pioneering company focused on scalable, low-power semiconductor technology for minimally-invasive neural implant applications. The company aims to revolutionize neurological care by developing compact, customizable devices that offer enhanced sensing, stimulation, and processing capabilities. With significant R&D funding and strategic partnerships with leading institutions, MintNeuro is poised to transform treatment options for patients with neurological disorders. Their innovative solutions promise to make neural implants more accessible, safer, and effective.